Stockscreener 앱 받기
0.576
7.20%
-0.0447
시장 영업 전:
.59
0.014
+2.43%
전일 마감가:
$0.6207
열려 있는:
$0.63
하루 거래량:
190.08K
Relative Volume:
0.17
시가총액:
$9.07M
수익:
-
순이익/손실:
$-29.56M
주가수익비율:
-0.2926
EPS:
-1.9688
순현금흐름:
$-21.21M
1주 성능:
-29.96%
1개월 성능:
+6.27%
6개월 성능:
-80.86%
1년 성능:
-71.90%
1일 변동 폭
$0.5696
$0.6448
1주일 범위
$0.5696
$0.7771
52주 변동 폭
$0.4606
$7.20
Calcimedica Inc Stock (CALC) Company Profile
명칭
Calcimedica Inc
전화
858-952-5500
주소
505 COAST BOULEVARD SOUTH, LA JOLLA
Compare CALC vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
0.576 | 9.07M | 0 | -29.56M | -21.21M | -1.9688 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Calcimedica Inc Stock (CALC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
Calcimedica Inc 주식(CALC)의 최신 뉴스
If You Invested $1,000 in CALCIMEDICA INC (CALC) - Stock Titan
Revenue Check: Does CalciMedica Inc meet Warren Buffetts criteria2026 Drop Watch & Detailed Earnings Play Alerts - baoquankhu1.vn
Big Picture: Does CalciMedica Inc meet Warren Buffetts criteriaShare Buyback & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
CalciMedica receives Nasdaq delisting notices for market value and bid price - Investing.com India
CalciMedica Receives Nasdaq Deficiency Notices on Listing Standards - TipRanks
CalciMedica Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
CalciMedica (NASDAQ: CALC) faces Nasdaq market value and $1 bid price breaches - Stock Titan
Analysis Recap: Can CalciMedica Inc outperform in the next rally2026 News Drivers & Fast Entry High Yield Stock Tips - baoquankhu1.vn
US Market Recap: Is CalciMedica Inc stock a smart retirement pick2026 Price Momentum & Daily Price Action Insights - baoquankhu1.vn
CALCCALCIMEDICA INC Latest Stock News & Market Updates - Stock Titan
[EFFECT] CalciMedica, Inc. SEC Filing - Stock Titan
Analysts’ Top Healthcare Picks: Dianthus Therapeutics (DNTH), CalciMedica (CALC) - The Globe and Mail
Oppenheimer Cuts CalciMedica (NASDAQ:CALC) Price Target to $10.00 - Defense World
Aug Highlights: Can CalciMedica Inc outperform in the next rally2025 Top Gainers & Consistent Profit Trading Strategies - baoquankhu1.vn
Performance Recap: Should I set a stop loss on CalciMedica Inc2025 Momentum Check & Safe Entry Point Identification - baoquankhu1.vn
CalciMedica, Inc. Common Stock share price - Mint
CalciMedica (CALC) Receives Updated Analyst Rating from Oppenhei - GuruFocus
Oppenheimer Adjusts CalciMedica Price Target to $10 From $20, Maintains Outperform Rating - marketscreener.com
CalciMedica price target lowered to $10 from $20 at Oppenheimer - TipRanks
CALC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Analysts’ Opinions Are Mixed on These Healthcare Stocks: CalciMedica (CALC) and Talphera (TLPH) - The Globe and Mail
Calcimedica Inc files for mixed shelf of up to $125 millionSEC filing - marketscreener.com
Calcimedica Inc Files For Mixed Shelf Of Up To $125 MillionSEC Filing - TradingView
CalciMedica (NASDAQ: CALC) files shelf to offer up to $125M in securities - Stock Titan
CalciMedica, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
CalciMedica (NASDAQ: CALC) outlines Auxora pipeline, halted AKI trial and going concern risk - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
CalciMedica (Nasdaq: CALC) widens 2025 loss while advancing Auxora and PAH candidate - Stock Titan
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates - PR Newswire
CalciMedica, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Retail Trends: Whats next for CalciMedica Inc stock2025 Sector Review & Technical Entry and Exit Tips - baoquankhu1.vn
CALC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CALC SEC FilingsCALCIMEDICA INC 10-K, 10-Q, 8-K Forms - Stock Titan
Jobs Data: Is Vistagen Therapeutics Inc. stock a top pick in earnings seasonGold Moves & Reliable Intraday Trade Alerts - baoquankhu1.vn
Does CalciMedica Inc. meet Warren Buffett’s criteria2025 Stock Rankings & Weekly High Conviction Ideas - mfd.ru
CALC Should I Buy - Intellectia AI
Should I set a stop loss on CalciMedica Inc.July 2025 Momentum & Weekly Watchlist for Consistent Profits - mfd.ru
Aug Highlights: What’s the fair value of DUK.PRA stockQuarterly Trade Review & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Earnings Risk: Does CalciMedica Inc meet Warren Buffetts criteria2025 Price Momentum & Technical Pattern Recognition Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
How Is The Market Feeling About CalciMedica Inc? - Benzinga
What is CalciMedica Inc.’s book value per shareWeekly Trend Summary & AI Enhanced Trading Signals - mfd.ru
CalciMedica downgraded to Neutral from Buy at H.C. Wainwright - TipRanks
This CalciMedica Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday - Benzinga
CalciMedica Shares Plunge After Discontinuing Phase II AKI Study - Citeline News & Insights
CalciMedica stock downgraded to Neutral by H.C. Wainwright after trial halt - Investing.com Canada
CalciMedica’s stock drops 75% on acute kidney injury trial termination - Clinical Trials Arena
CalciMedica discontinues AKI trial following safety concerns By Investing.com - Investing.com South Africa
CALC Stock Slumped 76% On Wednesday — Here’s Why - Stocktwits
CalciMedica discontinues Phase 2 KOURAGE trial following committee recommendation By Investing.com - Investing.com Nigeria
CalciMedica Discontinues Trial, Stock Faces Volatility - intellectia.ai
Calcimedica Inc (CALC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):